- NCIt
- C8101
Loading cancer entity…
Loading cancer entity…
Clinical trials
1,164 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00003144 | Chemotherapy and Amifostine in Treating Patients With Recurrent or Refractory Solid Tumors | completed | Phase 1 | 44 | NYU Langone HealthOTHER | 1 | Mar 28, 2011 | clinicaltrials |
| NCT00003331 | Combination Chemotherapy in Treating Patients With Advanced Cancer | completed | Phase 1 | 30 | NYU Langone HealthOTHER | 1 | Mar 28, 2011 | clinicaltrials |
| NCT00004105 |
| Combination Chemotherapy in Treating Patients With Advanced Cancer |
| completed |
| Phase 1 / Phase 2 |
| — |
| NYU Langone HealthOTHER |
| 1 |
| Mar 28, 2011 |
| clinicaltrials |
| NCT00004030 | VX-853 in Treating Patients With Solid Tumors Who Are Receiving Liposomal Doxorubicin | completed | Phase 1 / Phase 2 | 45 | Georgetown UniversityOTHER | 1 | Mar 24, 2011 | clinicaltrials |
| NCT00020748 | Epirubicin Plus Irinotecan in Treating Patients With Advanced Cancer | completed | Phase 1 | — | Georgetown UniversityOTHER | 1 | Mar 24, 2011 | clinicaltrials |
| NCT00003294 | Chemotherapy Given With Amifostine and Filgrastim in Treating Patients With Recurrent or Metastatic Cancer | completed | Phase 1 | 24 | Roswell Park Cancer InstituteOTHER | 1 | Mar 7, 2011 | clinicaltrials |
| NCT00003882 | Anhydrovinblastine in Treating Patients With Advanced Recurrent Solid Tumors | completed | Phase 1 | 10 | Roswell Park Cancer InstituteOTHER | 1 | Mar 7, 2011 | clinicaltrials |
| NCT00024141 | Irinotecan Followed by Fluorouracil in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | Roswell Park Cancer InstituteOTHER | 1 | Mar 7, 2011 | clinicaltrials |
| NCT00033566 | S-3304 in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | Roswell Park Cancer InstituteOTHER | 1 | Mar 7, 2011 | clinicaltrials |
| NCT00459836 | PR-104 and Docetaxel or Gemcitabine in Treating Patients With Solid Tumors | completed | Phase 1 | 42 | Proacta, IncorporatedINDUSTRY | 2 | Mar 2, 2011 | clinicaltrials |
| NCT00646139 | KX2-391 in Treating Patients With Advanced Solid Tumors or Lymphoma That Did Not Respond to Treatment | completed | Phase 1 | 7 | Roswell Park Cancer InstituteOTHER | 1 | Mar 2, 2011 | clinicaltrials |
| NCT00006086 | BMS-188797 and Carboplatin in Treating Patients With Advanced Nonhematologic Cancer | completed | Phase 1 | — | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 9, 2010 | clinicaltrials |
| NCT00002915 | Penclomedine in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Aug 9, 2010 | clinicaltrials |
| NCT00003289 | UCN-01 in Treating Patients With Advanced Cancer | completed | Phase 1 | — | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Aug 9, 2010 | clinicaltrials |
| NCT00047242 | UCN-01 and Irinotecan in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 30 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Aug 9, 2010 | clinicaltrials |
| NCT00368914 | Sirolimus in Treating Patients With Metastatic or Unresectable Solid Tumors | completed | Phase 1 | 30 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Aug 9, 2010 | clinicaltrials |
| NCT00002604 | O(6)-Benzylguanine and Carmustine in Treating Patients With Solid Tumors | completed | Phase 1 | 28 | Case Comprehensive Cancer CenterOTHER | 1 | Jul 8, 2010 | clinicaltrials |
| NCT00388089 | Bortezomib and Topotecan in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 24 | University of California, DavisOTHER | 1 | Jun 29, 2010 | clinicaltrials |
| NCT00003567 | Gene Therapy and Chemotherapy in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma | terminated | Phase 1 | 8 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 11, 2010 | clinicaltrials |
| NCT00005642 | SU5416 in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 19 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 11, 2010 | clinicaltrials |
| NCT00005819 | Combination Chemotherapy in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 21 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 11, 2010 | clinicaltrials |
| NCT00006018 | Paclitaxel and BMS-214662 in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 5 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 11, 2010 | clinicaltrials |
| NCT00006372 | Combination Chemotherapy in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 10 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 11, 2010 | clinicaltrials |
| NCT00006465 | Combination Chemotherapy in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 22 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 11, 2010 | clinicaltrials |
| NCT00253344 | Lenalidomide and Docetaxel in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 33 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 11, 2010 | clinicaltrials |
| NCT00376727 | Cetuximab in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 27 | University of California, DavisOTHER | 1 | Mar 29, 2010 | clinicaltrials |
| NCT00387322 | Pemetrexed Disodium and Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors | completed | Phase 1 / Phase 2 | 42 | University of California, DavisOTHER | 1 | Mar 29, 2010 | clinicaltrials |
| NCT00003082 | Monoclonal Antibody Therapy in Treating Patients With Advanced Cancer | completed | Phase 1 | 27 | University of ArizonaOTHER | 1 | Mar 16, 2010 | clinicaltrials |
| NCT00084513 | Trastuzumab and Imatinib Mesylate in Treating Patients With Recurrent or Metastatic HER2/Neu-Expressing Cancer | completed | Phase 1 | 18 | Fox Chase Cancer CenterOTHER | 1 | Feb 12, 2010 | clinicaltrials |
| NCT00025454 | R115777 in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | City of Hope Medical CenterOTHER | 1 | Feb 8, 2010 | clinicaltrials |
| NCT00091325 | Green Tea Extract (Polyphenon E) in Preventing Cancer in Healthy Participants | completed | Phase 1 | — | University of ArizonaOTHER | 1 | Jan 20, 2010 | clinicaltrials |
| NCT00006464 | UCN-01 and Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors | completed | Phase 1 | — | City of Hope Medical CenterOTHER | 1 | Jan 15, 2010 | clinicaltrials |
| NCT00002901 | Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function | completed | Phase 1 | — | City of Hope Medical CenterOTHER | 1 | Jan 13, 2010 | clinicaltrials |
| NCT00004220 | Oxaliplatin and Gemcitabine in Treating Patients With Advanced Cancer | completed | Phase 1 | — | City of Hope Medical CenterOTHER | 1 | Jan 13, 2010 | clinicaltrials |
| NCT00004243 | Docetaxel and Oxaliplatin in Treating Patients With Metastatic or Recurrent Solid Tumor | completed | Phase 1 | — | City of Hope Medical CenterOTHER | 1 | Jan 13, 2010 | clinicaltrials |
| NCT00006257 | SU5416 and Paclitaxel in Treating Patients With Advanced Cancer | completed | Phase 1 | — | City of Hope Medical CenterOTHER | 1 | Jan 13, 2010 | clinicaltrials |
| NCT00005077 | Oxaliplatin in Treating Patients With Advanced Cancer Plus Liver Dysfunction | completed | Phase 1 | — | City of Hope Medical CenterOTHER | 1 | Jan 6, 2010 | clinicaltrials |
| NCT00006485 | Flavopiridol and Irinotecan in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 15, 2009 | clinicaltrials |
| NCT00544063 | Capecitabine, Irinotecan, and Oxaliplatin in Treating Patients With Metastatic Cancer | unknown | Phase 1 | 33 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Dec 15, 2009 | clinicaltrials |
| NCT00004877 | BMS-214662 in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 3, 2009 | clinicaltrials |
| NCT00004923 | Docetaxel and Irinotecan in Treating Patients With Advanced Solid Tumors | completed | Phase 1 / Phase 2 | 47 | Yale UniversityOTHER | 1 | Aug 25, 2009 | clinicaltrials |
| NCT00037804 | Irinotecan in Treating Patients With Refractory Solid Tumors and Liver Dysfunction | completed | Phase 1 | — | PfizerINDUSTRY | 1 | Aug 14, 2009 | clinicaltrials |
| NCT00004063 | Cisplatin, Gemcitabine, Interferon Alfa, and Hyperthermia in Treating Patients With Advanced Cancer | unknown | Phase 1 / Phase 2 | 30 | The University of Texas Health Science Center, HoustonOTHER | 1 | Apr 30, 2009 | clinicaltrials |
| NCT00003705 | BMS-184476 in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | San Antonio Cancer InstituteOTHER | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00005611 | BMS-188797 in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Treatment | unknown | Phase 1 | — | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 0 | Jul 24, 2008 | clinicaltrials |
| NCT00043095 | BMS-247550 and Gemcitabine in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00100958 | Indole-3-Carbinol in Preventing Cancer in Healthy Participants | completed | Phase 1 | — | University of KansasOTHER | 1 | Jul 24, 2008 | clinicaltrials |
Data updated 22 days agoSource updated Mar 28, 2011source: clinicaltrials